NO992298L - Konformasjonsbegrensede LH-RH analoger, anvendelse derav og farmas°ytiske sammensetninger inneholdende disse - Google Patents

Konformasjonsbegrensede LH-RH analoger, anvendelse derav og farmas°ytiske sammensetninger inneholdende disse

Info

Publication number
NO992298L
NO992298L NO992298A NO992298A NO992298L NO 992298 L NO992298 L NO 992298L NO 992298 A NO992298 A NO 992298A NO 992298 A NO992298 A NO 992298A NO 992298 L NO992298 L NO 992298L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
compositions containing
analogs
conformationally limited
conformationally
Prior art date
Application number
NO992298A
Other languages
English (en)
Norwegian (no)
Other versions
NO992298D0 (no
Inventor
Rumi Delansorne
Jacques Paris
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of NO992298D0 publication Critical patent/NO992298D0/no
Publication of NO992298L publication Critical patent/NO992298L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/13Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
NO992298A 1996-11-14 1999-05-12 Konformasjonsbegrensede LH-RH analoger, anvendelse derav og farmas°ytiske sammensetninger inneholdende disse NO992298L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96402441A EP0842946A1 (en) 1996-11-14 1996-11-14 Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
PCT/EP1997/006322 WO1998021229A1 (en) 1996-11-14 1997-11-12 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
NO992298D0 NO992298D0 (no) 1999-05-12
NO992298L true NO992298L (no) 1999-07-08

Family

ID=8225315

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992298A NO992298L (no) 1996-11-14 1999-05-12 Konformasjonsbegrensede LH-RH analoger, anvendelse derav og farmas°ytiske sammensetninger inneholdende disse

Country Status (28)

Country Link
US (1) US6153587A (id)
EP (2) EP0842946A1 (id)
JP (1) JP2001503444A (id)
KR (1) KR20000068975A (id)
CN (1) CN1237979A (id)
AP (1) AP9901529A0 (id)
AT (1) ATE196914T1 (id)
AU (1) AU5481798A (id)
BR (1) BR9713060A (id)
CA (1) CA2270158A1 (id)
CO (1) CO4930283A1 (id)
CZ (1) CZ172899A3 (id)
DE (1) DE69703308D1 (id)
EE (1) EE9900174A (id)
HU (1) HUP0000249A3 (id)
ID (1) ID21990A (id)
IL (1) IL129821A0 (id)
JO (1) JO1999B1 (id)
MA (1) MA26447A1 (id)
NO (1) NO992298L (id)
NZ (1) NZ335454A (id)
OA (1) OA11045A (id)
PE (1) PE16899A1 (id)
PL (1) PL333358A1 (id)
TN (1) TNSN97173A1 (id)
TR (1) TR199901054T2 (id)
WO (1) WO1998021229A1 (id)
ZA (1) ZA9710254B (id)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677184A (en) * 1994-04-19 1997-10-14 Takeda Chemical Industries, Ltd. CHO cells that express human LH-RH receptor
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
EP0998940A1 (en) * 1998-09-30 2000-05-10 Laboratoire Theramex Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
US7375085B1 (en) 1999-04-26 2008-05-20 Ajinomoto Co., Inc. Melanocyte-stimulating hormone inhibitors
WO2008033924A2 (en) * 2006-09-12 2008-03-20 Board Of Regents Of The University Of Nebraska Methods and compositions for targeted delivery of therapeutic agents
US20230374071A1 (en) * 2020-10-08 2023-11-23 Dignify Therapeutics, Llc Compositions for inducing urinary voiding and defecation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377515A (en) * 1979-10-01 1983-03-22 Merck & Co., Inc. Long lasting agonists and antagonists of LH-RH
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CZ172899A3 (cs) 1999-08-11
TNSN97173A1 (fr) 2005-03-15
EP0937101A1 (en) 1999-08-25
PE16899A1 (es) 1999-02-19
HUP0000249A2 (en) 2000-07-28
DE69703308D1 (de) 2000-11-16
EP0937101B1 (en) 2000-10-11
PL333358A1 (en) 1999-12-06
ATE196914T1 (de) 2000-10-15
US6153587A (en) 2000-11-28
NZ335454A (en) 2000-10-27
CN1237979A (zh) 1999-12-08
JO1999B1 (en) 1999-05-15
JP2001503444A (ja) 2001-03-13
EE9900174A (et) 1999-12-15
HUP0000249A3 (en) 2000-11-28
ZA9710254B (en) 1998-05-28
OA11045A (en) 2003-03-07
NO992298D0 (no) 1999-05-12
AP9901529A0 (en) 1999-06-30
CO4930283A1 (es) 2000-06-27
BR9713060A (pt) 2000-04-11
AU5481798A (en) 1998-06-03
IL129821A0 (en) 2000-02-29
WO1998021229A1 (en) 1998-05-22
TR199901054T2 (xx) 1999-07-21
MA26447A1 (fr) 2004-12-20
EP0842946A1 (en) 1998-05-20
CA2270158A1 (en) 1998-05-22
KR20000068975A (ko) 2000-11-25
ID21990A (id) 1999-08-19

Similar Documents

Publication Publication Date Title
JO2034B1 (en) Isotopes of the hormone peptide its uses and the chemical compounds it contains
WO2002098856A3 (en) Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
ES2154167A1 (es) Aminoderivados ciclicos antagonistas del receptor ccr-3.
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
BR0012243A (pt) Triflúor butenos nematocidas
EA200100519A1 (ru) Композиции на основе тонкоизмельченного эплеренона
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
EP0695171A1 (en) GONADOTROPINE CONTAINING FREEZER DRIED DROPS
ATE231872T1 (de) Thiazolopyrimidinderivate
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
MX9801987A (es) Nuevos derivados de aminoacido, su obtencion y su uso.
TR200000152T2 (tr) Yeni bileşikler.
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
BR0016952A (pt) Compostos derivados de fenil-piperazina substituìdos, composição farmacêutica, uso e método
AR015945A1 (es) Composiciones de spray para el cabello autofobicas
ES2171018T3 (es) Uso de agentes inmunomoduladores.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
NO992298L (no) Konformasjonsbegrensede LH-RH analoger, anvendelse derav og farmas°ytiske sammensetninger inneholdende disse
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
NO963331L (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application